We therefore utilized an anti-CD45RA antibody to immunoprecipitate total CD45RABC from equivalent numbers of input AML cells and HSPCs and subsequently probed for E-selectin binding capacity. This evidence concerns the gene SELE and acute myeloid leukemia.